Physician and Patient Preferences for the Treatment of Metastatic Castration-Sensitive and Castration-Resistant Prostate Cancer: A Best-Worst Scaling Study in Japan

Physician and Patient Preferences for the Treatment of Metastatic Castration-Sensitive and Castration-Resistant Prostate Cancer: A Best-Worst Scaling Study in Japan

Abstract Introduction Despite many prostate cancer (PC) treatment options in Japan, physicians’ and patients’ preferences in metastatic castration-sensitive PC (mCSPC) and castration-resistant PC (CRPC) are unclear. Methods For this cross-sectional study, an online questionnaire survey based on the...

Full description

Saved in:
Bibliographic Details
Main Authors: Takahiro Kimura, Noriko Takahashi, Keiko Asakawa, Atsushi Saito, Takeshi Mitomi, Takumi Lee, Mika Matsumura
Format: Article
Language:English
Published: Adis, Springer Healthcare 2025-02-01
Series:Oncology and Therapy
Subjects:
Best–worst scaling
Castration-resistant prostate cancer
Metastatic castration-sensitive prostate cancer
Patient
Physician
Treatment preference
Online Access:https://doi.org/10.1007/s40487-025-00326-6
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1007/s40487-025-00326-6

Similar Items